Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04708223 · ClinicalTrials.gov registry record · NA

Prospective, Split-mouth, Comparative Study to Compare Clinical Outcomes of Two Different Posterior Composite

A NA study, sponsored by Ivoclar Vivadent.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT04708223 is a NA study that has completed, run by Ivoclar Vivadent. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04708223, a NA study, has completed, sponsored by Ivoclar Vivadent.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

The objective of this 2-year split mouth comparative study, a randomized controlled study, is to determine whether the simplified placement procedure of the ultra-rapid polymerizing Tetric PowerFlow/ Tetric PowerFill with a reduced light polymerization time (3 s), yields the same clin-ical results as widely used commercially available dental composites (Tetric EvoCeram Bulk Fill, Tetric EvoFlow Bulk Fill) requiring up to 40 seconds of light polymerization time.

Interventions

  • DEVICE Direct restorative treatment with fast-curing composites (Tetric PowerFill/ Tetric PowerFlow)
  • DEVICE Direct restorative treatment with conventionally applied composites (Tetric EvoCeram Bulk Fill/ Tetric EvoFlow Bulk Fill)

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2018-09-01
Est. Completion 2022-05-16
Phase NA

Sponsor

Ivoclar Vivadent

4 total trials

What the Registry Record Tells You About NCT04708223

The ClinicalTrials.gov registry entry for NCT04708223 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ivoclar Vivadent, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Direct restorative treatment with fast-curing composites (Tetric PowerFill/ Tetric PowerFlow) is the first listed.

NCT04708223 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04708223 about?

NCT04708223 is a clinical study titled "Prospective, Split-mouth, Comparative Study to Compare Clinical Outcomes of Two Different Posterior Composite". The objective of this 2-year split mouth comparative study, a randomized controlled study, is to determine whether the simplified placement procedure of the ultra-rapid polymerizing Tetric PowerFlow/ Tetric PowerFill with a reduced light polymerization time (3 s), yields the same clin-ical results a...

What is the current status of trial NCT04708223?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2018-09-01. Estimated completion is 2022-05-16.

What interventions are being tested in trial NCT04708223?

The interventions under investigation include: Direct restorative treatment with fast-curing composites (Tetric PowerFill/ Tetric PowerFlow) (DEVICE), Direct restorative treatment with conventionally applied composites (Tetric EvoCeram Bulk Fill/ Tetric EvoFlow Bulk Fill) (DEVICE).

Who is sponsoring clinical trial NCT04708223?

This trial is sponsored by Ivoclar Vivadent, which has 4 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.